Global Oncology Information Systems Market, By Products and Services (Solutions, Professional Services), By Application (Medical Oncology, Surgical Oncology) – Industry Trends and Forecast to 2029
Market Analysis and Size
The global oncology information systems market is expected to witness significant growth during the forecast period. This software predicts treatment outcomes, plans treatment, and exchanges cancer patient information across healthcare organizations. These benefits improve the safety and efficacy of cancer treatment for patients. OIS assists physicians and surgeons in selecting the most appropriate therapy to improve the survival rates of cancer patients. Hence, it is of great importance to market growth.
Data Bridge Market Research analyses a growth rate in the global oncology information systems market in the forecast period 2022-2029. The expected CAGR of global oncology information systems market is tend to be around 7.10% in the mentioned forecast period. The market was valued at USD 2.40 billion in 2021, and it would grow upto USD 4.15 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
The oncology information system market includes software and services for comprehensive information and imaging management that facilitate the management and optimization of cancer patient profiles and treatments. The patient portfolio is managed in medical facilities such as clinics, hospitals and laboratories by software called electronic medical records (EHRs). This software is used to predict patient outcomes, plan treatment, and share information about cancer patients between medical institutions. These benefits improve the safety and efficacy of cancer treatment in patients. Oncology information systems help physicians and surgeons choose the most appropriate treatments to improve the survival of cancer patients.
Report Scope and Market Segmentation
Report Metric |
Details |
Forecast Period |
2022 to 2029 |
Base Year |
2021 |
Historic Years |
2020 (Customizable to 2014 - 2019) |
Quantitative Units |
Revenue in USD Billion, Volumes in Units, Pricing in USD |
Segments Covered |
By Products & Services (Solutions, Professional Services), By Application (Medical Oncology, Surgical Oncology) |
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
Market Players Covered |
Koninklijke Philips N.V. (Netherlands), Varian Medical Systems, Inc (U.K), McKesson Corporation (U.S.), Siemens (Germany), Elekta (Sweden), Epic Systems Corporation (U.S.), IBM (U.S.), Cerner Corporation (U.S.), Advanced Data Systems (U.S.), BMSI Partners, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), AmerisourceBergen Corporation (U.S.), General Electric (U.S.), Accuray Incorporated (U.S.), OPTUM Inc., (U.S.), Allscripts Healthcare Solutions, Inc. (U.S.), MICA Information Systems, Inc. (U.S.), CureMD Healthcare (U.S.), EndoSoft LLC (U.S.), and RaySearch Laboratories (Sweden) |
Market Opportunities |
|
Global Oncology Information Systems Market Dynamics
Drivers
- Increasing Prevalence of Cancer
The increasing incidence of cancer worldwide is one of the major contributors to the growth of the oncology information system market. According to GLOBOCAN 2020, there will be 19.29 million new cancer cases worldwide in 2020, increasing to 28.4 million by 2040. (up 47 %). The prevalence of cancer worldwide (prevalence over 5 years, or total number of cancer patients over the last 5 years) is estimated to be 50.6 million. Therefore, the increased prevalence of cancer supports the demand for OIS to streamline patient information and data management and ultimately drives the oncology information system market.
Opportunities
- Demand for Streamlining Patient Information
The growing demand for OIS to streamline patient information and data management has led to a growing demand for different types of OIS software. Increased investment in cancer research by companies is projected to drive market growth. The market is expected to expand significantly in the coming years, and businesses are increasingly investing in the development of innovative and technologically advanced products.
Restraints/Challenges
- Lack of skilled professionals
The lack of qualified personnel who are unable to use these systems and softwares could curb the global oncology information systems market growth over a forecast period.
- High Cost
High cost of these software systems can hinder the growth of the global oncology information systems market even though the prevalence of the disease are high.
This global oncology information systems market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global oncology information systems market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Global Oncology Information Systems Market
Given the current situation, COVID-19 has caused an unprecedented global public health crisis that has affected virtually every business, and its long-term consequences are expected to have an impact on industry growth during the forecast period.
The shutdown impacted both the manufacturing and shipping of essential healthcare items. The closure of many hospitals and oncology clinics during the epidemic reduced demand for OIS solutions. Furthermore, hospitals focused primarily on COVID-19 patient management, limiting their ability to sell and implement oncology information systems. Increased vaccination rates, on the other hand, will help to stabilise the market. As a result, the market is expected to grow rapidly following COVID, as all suspended and postponed procedures will resume with the decline in COVID cases.
Global Oncology Information Systems Market Scope
The global oncology information systems market is segmented on the basis of product and services and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Products And Services
- Solutions
- Professional Services
Application
- Medical Oncology
- Surgical Oncology
Oncology Information Systems Market Regional Analysis/Insights
The global oncology information systems market is analysed and market size insights and trends are provided by product and services and application as referenced above.
The major countries covered in the global oncology information systems market are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the oncology information systems market due to the high demand for better healthcare facilities, prevalence of reimbursement policies and high prevalence of cancer.
Asia-Pacific is expected to witness significant growth due to the prevalence of cancer along with increasing number of government initiatives to create awareness among the population about cancer.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Oncology Information Systems Market Share Analysis
The global oncology information systems market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global oncology information systems market.
Key players operating in the global oncology information systems market include:
- Koninklijke Philips N.V. (Netherlands)
- Varian Medical Systems, Inc (U.K)
- McKesson Corporation (U.S.)
- Siemens (Germany)
- Elekta (Sweden)
- Epic Systems Corporation (U.S.)
- IBM (U.S.)
- Cerner Corporation (U.S.)
- Advanced Data Systems (U.S.)
- BMSI Partners, Inc. (U.S.)
- F. Hoffmann-La Roche AG (Switzerland)
- AmerisourceBergen Corporation (U.S.)
- General Electric (U.S.)
- Accuray Incorporated (U.S.)
- OPTUM Inc., (U.S.)
- Allscripts Healthcare Solutions, Inc. (U.S.)
- MICA Information Systems, Inc. (U.S.)
- CureMD Healthcare (U.S.)
- EndoSoft LLC (U.S.)
- RaySearch Laboratories (Sweden)
SKU-